Drug intelligence / Profile preview

oligo-lactic acid

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Oligo-lactic acid is a small molecule investigated for its potential therapeutic effects in chronic kidney disease. Preclinical studies in mice have shown that it can alleviate chronic kidney disease by inhibiting inflammation and modulating the gut microbiota.

Beyond the preview

Go deeper on oligo-lactic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on oligo-lactic acid.

Explore the full profile